Literature DB >> 29694995

Respiratory Support in Bronchiolitis: Trial Evidence.

Steve Cunningham1.   

Abstract

Acute viral lower respiratory tract infection is frequently associated with hypoxemia and respiratory distress, sometimes progressing to hypercarbia and respiratory failure. In recent years, trials have assessed the effects of oxygen supplementation and respiratory support with high-flow oxygen therapy. An oxygen saturation target of 90% is as safe and clinically effective as 94% in infants with bronchiolitis. Trials of high-flow humidified oxygen have demonstrated safety, but as yet poorly demarcated an appropriate place for use within the clinical course of the disease. Effective trials of continuous positive airway pressure are lacking and urgently required. The trials reported to date have highlighted the need for common outcomes in relation to treatment failure. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29694995     DOI: 10.1055/s-0038-1637765

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  3 in total

1.  Predicting Failure of Non-Invasive Ventilation With RAM Cannula in Bronchiolitis.

Authors:  Mia Maamari; Gustavo Nino; James Bost; Yao Cheng; Anthony Sochet; Matthew Sharron
Journal:  J Intensive Care Med       Date:  2021-01-08       Impact factor: 3.510

2.  Update on current views and advances on RSV infection (Review).

Authors:  Ioannis N Mammas; Simon B Drysdale; Barbara Rath; Maria Theodoridou; Georgia Papaioannou; Alexia Papatheodoropoulou; Eirini Koutsounaki; Chryssie Koutsaftiki; Eleftheria Kozanidou; Vassilis Achtsidis; Paraskevi Korovessi; George P Chrousos; Demetrios A Spandidos
Journal:  Int J Mol Med       Date:  2020-06-15       Impact factor: 4.101

3.  Nasogastric tube, a warning sign for high-flow nasal cannula failure in infants with bronchiolitis.

Authors:  Milena Siciliano Nascimento; Danielle E R Quinto; Gisele C Z Oliveira; Celso M Rebello; Cristiane do Prado
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.